日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

CRIF1-CDK2 Interface Inhibitors Enhance Taxol Inhibition of the Lethal Triple-Negative Breast Cancer

CRIF1-CDK2 界面抑制剂增强紫杉醇对致命三阴性乳腺癌的抑制作用

Xiaoye Sang, Nassira Belmessabih, Ruixuan Wang, Preyesh Stephen, Sheng-Xiang Lin

Mutual regulations and breast cancer cell control by steroidogenic enzymes: Dual sex-hormone receptor modulation upon 17β-HSD7 inhibition

类固醇生成酶的相互调节和乳腺癌细胞控制:17β-HSD7 抑制对性激素受体的双重调节

Xiaoye Sang, Hui Han, Tang Li, Sheng-Xiang Lin

Synergistic control of sex hormones by 17β-HSD type 7: a novel target for estrogen-dependent breast cancer

17β-HSD 7 型对性激素的协同控制:雌激素依赖性乳腺癌的新靶点

Xiaoqiang Wang, Catherine Gérard, Jean-François Thériault, Donald Poirier, Charles J Doillon, Sheng-Xiang Lin

Dendritic cell immunoreceptor is a new target for anti-AIDS drug development: identification of DCIR/HIV-1 inhibitors

树突状细胞免疫受体是抗艾滋病药物开发的新靶点:鉴定DCIR/HIV-1抑制剂

Alexandra A Lambert, Arezki Azzi, Sheng-Xiang Lin, Geneviève Allaire, Karianne P St-Gelais, Michel J Tremblay, Caroline Gilbert

17beta-hydroxysteroid dehydrogenase type 1 modulates breast cancer protein profile and impacts cell migration

17β-羟基类固醇脱氢酶 1 型调节乳腺癌蛋白质谱并影响细胞迁移

Juliette A Aka, Mouna Zerradi, François Houle, Jacques Huot, Sheng-Xiang Lin

Comparison of functional proteomic analyses of human breast cancer cell lines T47D and MCF7

人乳腺癌细胞系T47D和MCF7功能蛋白质组学分析比较

Juliette Adjo Aka, Sheng-Xiang Lin

The contribution of 17beta-hydroxysteroid dehydrogenase type 1 to the estradiol-estrone ratio in estrogen-sensitive breast cancer cells

17β-羟基类固醇脱氢酶 1 型对雌激素敏感型乳腺癌细胞中雌二醇-雌酮比率的贡献

Chen-Yan Zhang, Jiong Chen, Da-Chuan Yin, Sheng-Xiang Lin